Verve Therapeutics, Inc.
VERV
NASDAQ
Headlines
There are no news to display.
Filings
Tuesday, February 27, 2024
Sunday, December 31, 2023
Week of May 13 and 17 (est)
Price History
--
--
Corporate Info
617 603 0070
201 Brookline Avenue
Cambridge, MA 02215
Cambridge, MA 02215
Business Description
Verve Therapeutics, Inc., a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States. The...
more